Tevis Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,340
| Closed | -$454K | – | 98 |
|
|
2024
Q3 | $454K | Buy |
2,340
+13
| +0.6% | +$2.52K | 0.34% | 70 |
|
|
2024
Q2 | $539K | Sell |
2,327
-99
| -4% | -$23K | 0.43% | 63 |
|
|
2024
Q1 | $523K | Sell |
2,426
-11
| -0.5% | -$2.37K | 0.44% | 63 |
|
|
2023
Q4 | $631K | Sell |
2,437
-3
| -0.1% | -$776 | 0.58% | 52 |
|
|
2023
Q3 | $627K | Sell |
2,440
-9
| -0.4% | -$2.31K | 0.64% | 53 |
|
|
2023
Q2 | $698K | Buy |
2,449
+8
| +0.3% | +$2.28K | 0.68% | 49 |
|
|
2023
Q1 | $679K | Hold |
2,441
| – | – | 0.69% | 49 |
|
|
2022
Q4 | $676K | Sell |
2,441
-81
| -3% | -$22.4K | 0.72% | 48 |
|
|
2022
Q3 | $673K | Buy |
2,522
+49
| +2% | +$13.1K | 0.65% | 50 |
|
|
2022
Q2 | $504K | Buy |
2,473
+154
| +7% | +$31.4K | 0.48% | 61 |
|
|
2022
Q1 | $490K | Buy |
2,319
+79
| +4% | +$16.7K | 0.44% | 65 |
|
|
2021
Q4 | $536K | Buy |
+2,240
| New | +$536K | 0.47% | 68 |
|